Alcon annual dividends paid
2007
2008
2009
2010
2019
2020
2021
2022
2023
2024
2025
Alcon Dividends Paid Growth & History (ALC)
Alcon paid $166.0M in dividends during fiscal 2025.
View full Alcon company overviewAlcon annual dividends paid history
| Fiscal year | Period ended | Dividends paid | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $166.0M | $36.0M | +27.69% |
| 2024 | 2024-12-31 | $130.0M | $14.0M | +12.07% |
| 2023 | 2023-12-31 | $116.0M | $16.0M | +16.00% |
| 2022 | 2022-12-31 | $100.0M | $46.0M | +85.19% |
| 2021 | 2021-12-31 | $54.0M | $54.0M | — |
| 2020 | 2020-12-31 | $0 | $0 | — |
| 2019 | 2019-12-31 | $0 | — | — |
| 2010 | 2010-12-31 | $1.04B | −$11.0M | −1.05% |
| 2009 | 2009-12-31 | $1.05B | $299.0M | +39.92% |
| 2008 | 2008-12-31 | $749.0M | $136.0M | +22.19% |
| 2007 | 2007-12-31 | $613.0M | — | — |
Alcon quarterly dividends paid
Q3.08
Q3.09
Q3.10
Q1.21
Q4.24
Q4.25
| Fiscal quarter | Period ended | Dividends paid | Change | YoY change |
|---|---|---|---|---|
| Q4 2025 | 2025-12-31 | $0 | $0 | — |
| Q4 2024 | 2024-12-31 | $0 | — | — |
| Q1 2021 | 2021-02-23 | $54.0M | — | — |
| Q3 2010 | 2010-09-30 | $0 | $0 | — |
| Q3 2009 | 2009-09-30 | $0 | $0 | — |
| Q3 2008 | 2008-09-30 | $0 | — | — |
Alcon dividends paid trends
Over the last five fiscal years, Alcon's dividends paid increased from $0 to $166.0M, a change of $166.0M. The latest reported quarter, Q4 2025, shows $0.
About the metric
What dividends paid mean
Dividends paid are cash distributions made to shareholders. The history shows the company’s aggregate cash outflow for dividends, not the dividend per share, dividend yield, or the date an investor receives a payment.
Calculation and source
Reported cash dividends paid
TickerStat standardizes cash dividends paid to common or ordinary shareholders from official cash-flow filings. Reported zero-dividend periods remain zero and are not treated as missing data. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Alcon source filings ↗Community posts
Alcon completes $550 million Neurotech acquisition to enter MacTel treatment
Alcon ($ALC) has acquired Neurotech for $550 million, with additional payments dependent on commercial milestones. The transaction adds ENCELTO, a cell-based ocular therapy for adults with macular telangiectasia type 2. The product received ...
